Inova

The US Food and Drug Administration (FDA) has granted clearance through the de novo classification process for Inova Diagnostics’ NOVA View, an automated digital indirect fluorescent assay (IFA) microscope.

NOVA View comprises of a fluorescence microscope and software that acquires, analyses, stores and displays digital images of stained indirect immunofluorescent slides.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Developed to detect antinuclear antibodies (ANA), the new IFA microscope also received FDA 510(k) approval for NOVA Lite DAPI ANA Kit, an IFA reagent to be used with NOVA View.

The new automated digital IFA microscope, NOVA View, is the first FDA cleared microscope in the US, which will help laboratories that perform IFA for the detection of ANA.

"NOVA View comprises of a fluorescence microscope and software that acquires, analyses, stores and displays digital images of stained indirect immunofluorescent slides."

ANA is the first line laboratory test for the diagnosis of systemic lupus erythematosus and other systemic autoimmune rheumatic diseases.

See Also:

Simultaneously, the company also secured 510(k) clearance for NOVA Lite DAPI ANA Kit.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

NOVA View is intended as an aid in the detection and classification of certain antibodies by indirect immunofluorescence technology and it can only be used with cleared or approved in-vitro diagnostic assays that are indicated for use with the device.

The device carries out ANA pattern interpretation and predicts a pattern specific endpoint titer, after confirmation by the operator.

Inova Diagnostics Assay Development director Gabriella Lakos said: "NOVA View is a technology that fundamentally changes the way IFA is performed in diagnostic laboratories.

"NOVA View will bring efficiency and reliability to this traditionally labour intensive and subjective area of diagnostic immunology."

Image: NOVA View automated digital IFA microscope. Photo: courtesy of PRNewswire/ Inova Diagnostics.